References
- HR 3590. An Act Entitled The Patient Protection and Affordable Care Act. One Hundredth and Eleventh Congress of the United States of America. The US Government Printing Office, Washington, DC, USA (2010).
- Neumann PJ. Why don’t Americans use cost–effectiveness analysis? Am. J. Manag. Care10, 308–312 (2004).
- Fisher ES, Bynum JP, Skinner JS. Slowing the growth of health care costs – lessons from regional variation. N. Engl. J. Med.360, 849–852 (2009).
- Federal Coordinating Council for Comparative Effectiveness Research. Report to the President and the Congress. US Department of Health and Human Services, Washington, DC, USA (2009).
- Fendrick AM, Smith DG, Chernew ME, Shah SN. A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. Am. J. Manag. Care7, 861–867 (2001).
- Braithwaite RS, Rosen AB. Linking cost sharing to value: an unrivaled but unrealized public health opportunity. Ann. Intern. Med.146, 602–605 (2007).
- Braithwaite RS, Omokaro C, Justice AC, Nucifora K, Roberts MS. Can broader diffusion of value-based insurance design increase benefits from US healthcare without increasing costs? Evidence from a computer simulation model. PLoS Med.7(2), E1000234 (2010).